Poly(alkylcyanoacrylate) colloidal particles as vehicles for antitumour drug delivery:: A comparative study

被引:67
作者
Arias, Jose L. [1 ]
Adolfina Ruiz, M. [1 ]
Lopez-Viota, Margarita [1 ]
Delgado, Angel V. [2 ]
机构
[1] Univ Granada, Dept Pharm & Pharmaceut Technol, Fac Pharm, E-18071 Granada, Spain
[2] Univ Granada, Fac Sci, Dept Appl Phys, E-18071 Granada, Spain
关键词
biodegradable polymers; colloidal drug delivery systems; controlled release; multidrug resistance; poly(alkylcyanoacrylates);
D O I
10.1016/j.colsurfb.2007.09.018
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Because of the fundamental importance of new therapeutic routes for cancer treatment, a number of. systems based on colloidal particles as vehicles for the delivery of chemotherapeutic agents have been devised. The target is always to provide the proper dose of the antitumour agent only at the desired locus of action, thus reducing the unwanted side effects. The systems studied in this work are nanospheres of the biodegradable polymers poly(ethyl-2-cyanoacrylate), poly(butylcyanoacrylate), poly(hexyl cyanoacrylate) and poly(octylcyanoacrylate), all suitable for parenteral administration, as vehicles for 5-fluorouracil, a well studied drug used for the treatment of solid tumours. Two loading methods have been analyzed: the first one is based on drug addition during the process of generation of the particles, by an anionic emulsion/polymerization procedure, and the subsequent drug trapping in the polymeric network. The second method is based on surface adsorption in already formed nanoparticles, after incubation in the drug solution. A detailed investigation of the capabilities of the polymer particles to toad this drug is described. The main factors determining the drug incorporation to the polymer network were the type of monomer, the pH and the drug concentration. The release kinetics of 5-fluorouracil is found to be controlled by the pH of the release medium, the type of drug incorporation and the type of polymer. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:64 / 70
页数:7
相关论文
共 56 条
[41]  
Page ME, 1996, STP PHARMA SCI, V6, P298
[42]  
Peracchia MT, 1997, STP PHARMA SCI, V7, P513
[43]   Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications [J].
Pinto-Alphandary, H ;
Andremont, A ;
Couvreur, P .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 13 (03) :155-168
[44]   IN-VITRO EVALUATION OF POLYISOBUTYLCYANOACRYLATE NANOPARTICLES AS A CONTROLLED DRUG CARRIER FOR THEOPHYLLINE [J].
RADWAN, MA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (20) :2371-2375
[45]   A prospectus on tissue adhesives [J].
Reece, TB ;
Maxey, TS ;
Kron, IL .
AMERICAN JOURNAL OF SURGERY, 2001, 182 (02) :40S-44S
[46]   Study on the role of 5-fluorouracil in the polymerization of butylcyanoacrylate during the formation of nanoparticles [J].
Simeonova, M ;
Velichkova, R ;
Ivanova, G ;
Enchev, V ;
Abrahams, I .
JOURNAL OF DRUG TARGETING, 2004, 12 (01) :49-56
[47]  
Soma CE, 2000, BIOMATERIALS, V21, P1
[48]   DEGRADATION OF POLYBUTYL 2-CYANOACRYLATE MICROPARTICLES [J].
STEIN, M ;
HAMACHER, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 80 (2-3) :R11-R13
[49]   LONG CIRCULATING MICROPARTICULATE DRUG CARRIERS [J].
STOLNIK, S ;
ILLUM, L ;
DAVIS, SS .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :195-214
[50]   In vitro degradation of insulin-loaded poly (n-butylcyanoacrylate) nanoparticles [J].
Sullivan, CO ;
Birkinshaw, C .
BIOMATERIALS, 2004, 25 (18) :4375-4382